Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion type Assertion NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_head.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion description "[FAS (oncogenic antigen-519) is up-regulated in about 50% of breast cancers, is an indicator of poor prognosis, and has recently been functionally associated with the Her2/neu (erbB-2) oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_provenance.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion evidence source_evidence_literature NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_provenance.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion SIO_000772 15870086 NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_provenance.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion wasDerivedFrom befree-2016 NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_provenance.
- NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_assertion wasGeneratedBy ECO_0000203 NP493005.RAD5GULkc6vxizPCRy2Y3e1eNcuuKThZ_WeRb_T1qEtcg130_provenance.